Why Hire CNP Holders Rigorous designation criteria ensure CNP-designated professionals will be superior contributors to an organization's bottom-line. Customers are assured of high-quality network systems being used to develop and support products and services.
The investigational CAM2038 buprenorphine subcutaneous injection products for treatment of opioid addiction are being developed as once-weekly and once-monthly formulations, each with multiple doses, to cover all phases of treatment from initiation through maintenance.
Buprenorphine is a synthetic opioid medication that acts as a partial agonist at opioid receptorsâit does not produce the euphoria and sedation caused by heroin or other opioids but is able to reduce or eliminate withdrawal symptoms associated with opioid dependence and carries a low risk of overdose.